Literature DB >> 16566887

Developmental regression and mitochondrial dysfunction in a child with autism.

Jon S Poling1, Richard E Frye, John Shoffner, Andrew W Zimmerman.   

Abstract

Autistic spectrum disorders can be associated with mitochondrial dysfunction. We present a singleton case of developmental regression and oxidative phosphorylation disorder in a 19-month-old girl. Subtle abnormalities in the serum creatine kinase level, aspartate aminotransferase, and serum bicarbonate led us to perform a muscle biopsy, which showed type I myofiber atrophy, increased lipid content, and reduced cytochrome c oxidase activity. There were marked reductions in enzymatic activities for complex I and III. Complex IV (cytochrome c oxidase) activity was near the 5% confidence level. To determine the frequency of routine laboratory abnormalities in similar patients, we performed a retrospective study including 159 patients with autism (Diagnostic and Statistical Manual of Mental Disorders-IV and Childhood Autism Rating Scale) not previously diagnosed with metabolic disorders and 94 age-matched controls with other neurologic disorders. Aspartate aminotransferase was elevated in 38% of patients with autism compared with 15% of controls (P <.0001). The serum creatine kinase level also was abnormally elevated in 22 (47%) of 47 patients with autism. These data suggest that further metabolic evaluation is indicated in autistic patients and that defects of oxidative phosphorylation might be prevalent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566887      PMCID: PMC2536523          DOI: 10.1177/08830738060210021401

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

1.  Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease.

Authors:  D C Wallace; X X Zheng; M T Lott; J M Shoffner; J A Hodge; R I Kelley; C M Epstein; L C Hopkins
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

Review 2.  Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies.

Authors:  X X Zheng; J M Shoffner; A S Voljavec; D C Wallace
Journal:  Biochim Biophys Acta       Date:  1990-08-09

3.  Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation.

Authors:  W D Graf; J Marin-Garcia; H G Gao; S Pizzo; R K Naviaux; D Markusic; B A Barshop; E Courchesne; R H Haas
Journal:  J Child Neurol       Date:  2000-06       Impact factor: 1.987

4.  Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome.

Authors:  James J Fillano; Michael J Goldenthal; C Harker Rhodes; José Marín-García
Journal:  J Child Neurol       Date:  2002-06       Impact factor: 1.987

5.  Mitochondrial DNA abnormalities and autistic spectrum disorders.

Authors:  Roser Pons; Antoni L Andreu; Nicoletta Checcarelli; Maya R Vilà; Kristin Engelstad; Carolyn M Sue; Dikoma Shungu; Rita Haggerty; Darryl C de Vivo; Salvatore DiMauro
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

6.  Mitochondrial dysfunction in autistic patients with 15q inverted duplication.

Authors:  Pauline A Filipek; Jenifer Juranek; Moyra Smith; Lee Z Mays; Erica R Ramos; Maureen Bocian; Diane Masser-Frye; Tracy M Laulhere; Charlotte Modahl; M Anne Spence; J Jay Gargus
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

Review 7.  Should autistic children be evaluated for mitochondrial disorders?

Authors:  Tally Lerman-Sagie; Esther Leshinsky-Silver; Nathan Watemberg; Dorit Lev
Journal:  J Child Neurol       Date:  2004-05       Impact factor: 1.987

8.  Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain.

Authors:  M E Cornford; M Philippart; B Jacobs; A B Scheibel; H V Vinters
Journal:  J Child Neurol       Date:  1994-10       Impact factor: 1.987

Review 9.  Developmental regression in autism spectrum disorders.

Authors:  Sally J Rogers
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

10.  Infantile hypotonia as a presentation of Rett syndrome.

Authors:  Heidi A Heilstedt; Mona D Shahbazian; Brendan Lee
Journal:  Am J Med Genet       Date:  2002-08-15
  10 in total
  48 in total

Review 1.  Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

2.  Mitochondrial and ion channel gene alterations in autism.

Authors:  Moyra Smith; Pamela L Flodman; John J Gargus; Mariella T Simon; Kimberley Verrell; Richard Haas; Gail E Reiner; Robert Naviaux; Katherine Osann; M Anne Spence; Douglas C Wallace
Journal:  Biochim Biophys Acta       Date:  2012-04-17

3.  Genetics and the myth of vaccine encephalopathy.

Authors:  Asif Doja
Journal:  Paediatr Child Health       Date:  2008-09       Impact factor: 2.253

4.  Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features.

Authors:  Sneha Yadav; Virendra Tiwari; Manjari Singh; Rajnish K Yadav; Subhadeep Roy; Uma Devi; Swetlana Gautam; Jitendra Kumar Rawat; Mohd Nazam Ansari; Abdulaziz Sa Saeedan; Anand Prakash; Shubhini A Saraf; Gaurav Kaithwas
Journal:  J Physiol Biochem       Date:  2016-11-22       Impact factor: 4.158

5.  Cochlear Implantation in Children With Autism Spectrum Disorder.

Authors:  Adrien A Eshraghi; Ronen Nazarian; Fred F Telischi; Diane Martinez; Annelle Hodges; Sandra Velandia; Ivette Cejas-Cruz; Thomas J Balkany; Kaming Lo; Dustin Lang
Journal:  Otol Neurotol       Date:  2015-09       Impact factor: 2.311

Review 6.  Neurodevelopmental manifestations of mitochondrial disease.

Authors:  Marni J Falk
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

7.  Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.

Authors:  Asma M Khemakhem; Richard E Frye; Afaf El-Ansary; Laila Al-Ayadhi; Abir Ben Bacha
Journal:  Metab Brain Dis       Date:  2017-08-22       Impact factor: 3.584

8.  Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder.

Authors:  Afaf El-Ansary; Geir Bjørklund; Salvatore Chirumbolo; Osima M Alnakhli
Journal:  Metab Brain Dis       Date:  2017-05-11       Impact factor: 3.584

9.  15q11.2-13 duplication, mitochondrial dysfunction, and developmental disorders.

Authors:  Richard E Frye
Journal:  J Child Neurol       Date:  2009-06-17       Impact factor: 1.987

Review 10.  Neurometabolic disorders and dysfunction in autism spectrum disorders.

Authors:  Nassim Zecavati; Sarah J Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.